|
Post by brotherm1 on Apr 13, 2019 21:42:52 GMT -5
Right, but government is near sighted also and governed by political factions that frequently change with elections.
|
|
|
Post by cedafuntennis on Apr 14, 2019 12:22:58 GMT -5
Nice interview. I think the woman interviewing them asked some good questions, several of them were actually from people that wrote a question in to be asked. Lots of great information covered in this one. Towards the end, I would have asked Dr. Friedman why is he not giving his hospital patients Afrezza when it's so good for them. He's on the BOD yet he's not pushing the hospitals to allow Afrezza??? Something is rotten with this picture. Also not using a glucose monitor and he skated around the reason why not. I am way less than impressed with this guy!
|
|
|
Post by agedhippie on Apr 14, 2019 18:49:46 GMT -5
Nice interview. I think the woman interviewing them asked some good questions, several of them were actually from people that wrote a question in to be asked. Lots of great information covered in this one. Towards the end, I would have asked Dr. Friedman why is he not giving his hospital patients Afrezza when it's so good for them. He's on the BOD yet he's not pushing the hospitals to allow Afrezza??? Something is rotten with this picture. Also not using a glucose monitor and he skated around the reason why not. I am way less than impressed with this guy! They are different Dr Friedmans. The Dr Friedman on the podcast is Joel who is a ER doctor at NCH Baker Hospital , and the one on the BOD is Michael who is in management rather than medicine (and at 74 probably semi-retired)
|
|
|
Post by Clement on Apr 15, 2019 8:19:52 GMT -5
Slide 26 1H Anticipated Events:One of the listings is Completion of formulation work for unnamed compound for UTHR. I would love to see this happen and advance to the next stage. This quarter! Suppose the formulation work is completed as presented in the slide. UTHR will decide if the result meets criteria such as chemical stability and how it flies. If so, then this undisclosed compound will advance. And MNKD will receive $30 million.
|
|
|
Post by ktim on Apr 15, 2019 9:12:12 GMT -5
Slide 26 1H Anticipated Events:One of the listings is Completion of formulation work for unnamed compound for UTHR. I would love to see this happen and advance to the next stage. This quarter! Suppose the formulation work is completed as presented in the slide. UTHR will decide if the result meets criteria such as chemical stability and how it flies. If so, then this undisclosed compound will advance. And MNKD will receive $30 million. Though I believe we know from the agreement that only $15M is paid at that first decision point with the other $15M coming based on some not specified milestone. That's my recollection, which could be wrong.
|
|
|
Post by Clement on Apr 15, 2019 10:52:55 GMT -5
$15 million soon-ish and $15 million later cool
|
|
|
Post by cedafuntennis on Apr 15, 2019 13:03:14 GMT -5
Oh, thanks for the clarification. In any case, we need people on the BoD who will actively participate in the furthering of the company. Having tokens due to previous relationships with Dr. Mann is not useful and at this stage the company cannot afford both the money wasted and the lack of active participation. No lack of respect intended, but we just don't have the luxury of honorary BoD members at this stage of the game.
|
|
|
Post by mnholdem on Apr 15, 2019 17:42:39 GMT -5
“Lack of active participation”. Great phrase that describes the company’s MIA Chief Medical Officer. The medical community is ripe for diabetes control. What the heck has he been doing for the past two years?
|
|
|
Post by peppy on Apr 15, 2019 17:51:15 GMT -5
Slide 26 1H Anticipated Events:One of the listings is Completion of formulation work for unnamed compound for UTHR. I would love to see this happen and advance to the next stage. This quarter! Suppose the formulation work is completed as presented in the slide. UTHR will decide if the result meets criteria such as chemical stability and how it flies. If so, then this undisclosed compound will advance. And MNKD will receive $30 million.
|
|